Pro-inflammatory cytokines predominate in the brains of dogs with visceral leishmaniasis: A natural model of neuroinflammation during systemic parasitic infection

Veterinary Parasitology

Volumn 192, Issue 1-3, 2013, Pages 57-66

  Melo, Guilherme D ^a   Seraguci, Túlio F ^a   Schweigert, Augusto ^a   Silva, José Eduardo S ^a   Grano, Fernanda G ^a   Peiró, Juliana R ^a   Lima, Valéria M F ^a   Machado, Gisele F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Blood brain barrier; Central nervous system; Immune system; Inflammation; Leishmania infantum; RT qPCR

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DOG; DOWN REGULATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; LEISHMANIA INFANTUM; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE LOAD; SPLEEN; UPREGULATION; VISCERAL LEISHMANIASIS; ANIMAL; BLOOD BRAIN BARRIER; BRAZIL; DOG DISEASE; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; VETERINARY;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAZIL; CYTOKINES; DOG DISEASES; DOGS; FEMALE; IMMUNE SYSTEM; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; PARASITE LOAD; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN;

EID: 84871695068     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2012.11.002     Document Type: Article

References (90)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Alexandre-Pires G., de Brito M.T.V., Algueró C.r., Martins C., Rodrigues O.R., da Fonseca I.P., Santos-Gomes G. Canine leishmaniosis. Immunophenotypic profile of leukocytes in different compartments of symptomatic, asymptomatic and treated dogs. Vet. Immunol. Immunopathol. 2010, 137:275-283.
3. Aloisi F., Penna G., Cerase J., Menendez Iglesias B., Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 1997, 159:1604-1612.
4. Alvar J., Cañavate C., Molina R., Moreno J., Nieto J. Canine leishmaniasis. Adv. Parasitol. 2004, 57:1-88.
5. Ansari N.A., Saluja S., Salotra P. Elevated levels of interferon-γ, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin. Immunol. 2006, 119:339-345.
6. Baneth G., Koutinas A., Solano-Gallego L., Bourdeau P., Ferrer L. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 2008, 24:324-330.
7. Barbiéri C.L. Immunology of canine leishmaniasis. Parasite Immunol. 2006, 28:329-377.
8. Barbosa M.A.G., Alexandre-Pires G., Soares-Clemente M., Marques C., Rodrigues O.R., De Brito T.V., Da Fonseca I.P., Alves L.C., Santos-Gomes G.M. Cytokine gene expression in the tissues of dogs infected by Leishmania infantum. J. Comp. Pathol. 2011, 145:336-344.
9. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
10. Blavier A., Keroack S., Denerolle P., Goy-Thollot I., Chabanne L., Cadoré J.L., Bourdoiseau G. Atypical forms of canine leishmaniosis. Vet. J. 2001, 162:108-120.
11. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., Dingledine R. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 2003, 182:21-34.
12. Brionne T.C., Tesseur I., Masliah E., Wyss-Coray T. Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 2003, 40:1133-1145.
13. Campanelli A.P., Roselino A.M., Cavassani K.A., Pereira M.S.F., Mortara R.A., Brodskyn C.I., Gonçalves H.S., Belkaid Y., Barral-Netto M., Barral A., Silva J.S. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J. Infect. Dis. 2006, 193:1313-1322.
14. Chamizo C., Moreno J., Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet. Immunol. Immunopathol. 2005, 103:67-75.
15. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alvar J., Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat. Rev. Microbiol. 2007, 5:873-882.
16. Choi J., Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med. J. 2008, 49:1-18.
17. Ciaramella P., Corona M. Canine leishmaniasis: clinical and diagnostic aspects. Comp. Cont. Ed. Pract. Vet. 2003, 25:358-369.
18. de Vries H.E., Blom-Roosemalen M.C.M., Oosten M.v., de Boer A.G., van Berkel T.J.C., Breimer D.D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 1996, 64:37-43.
19. de Vries H.E., Kuiper J., Boer A.G.d., Berkel T.J.C.V., Breimer D.D. The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 1997, 49:143-156.
20. Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2009, 8:16-30.
21. Deininger M.H., Kremsner P.G., Meyermann R., Schluesener H.J. Differential cellular accumulation of transforming growth factor-β1, -β2, and -β3 in brains of patients who died with cerebral malaria. J. Infect. Dis. 2000, 181:2111-2115.
22. Diamond B., Huerta P.T., Mina-Osorio P., Kowal C., Volpe B.T. Losing your nerves? Maybe it's the antibodies. Nat. Rev. Immunol. 2009, 9:449-456.
23. Dohgu S., Takata F., Yamauchi A., Nakagawa S., Egawa T., Naito M., Tsuruo T., Sawada Y., Niwa M., Kataoka Y. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-β production. Brain Res. 2005, 1038:208-215.
24. Dohgu S., Yamauchi A., Takata F., Naito M., Tsuruo T., Higuchi S., Sawada Y., Kataoka Y. Transforming growth factor-β1 upregulates the tight junction and p-glycoprotein of brain microvascular endothelial cells. Cell. Mol. Neurobiol. 2004, 24:491-497.
25. Dubey J.P., Mattix M.E., Lipscomb T.P. Lesions of neonatally induced toxoplasmosis in cats. Vet. Pathol. 1996, 33:290-295.
26. Fischer H.-G., Nitzgen B., Reichmann G., Hadding U. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur. J. Immunol. 1997, 27:1539-1548.
27. Font A., Mascort J., Altimira J., Closa J.M., Vilafranca M. Acute paraplegia associated with vasculitis in a dog with leishmaniasis. J. Small Anim. Pract. 2004, 45:199-201.
28. Fujiwara S., Yasunaga S., Iwabuchi S., Masuda K., Ohno K., Tsujimoto H. Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Vet. Immunol. Immunopathol. 2003, 93:9-20.
29. Gantt K.R., Schultz-Cherry S., Rodriguez N., Jeronimo S.M.B., Nascimento E.T., Goldman T.L., Recker T.J., Miller M.A., Wilson M.E. Activation of TGF-β by Leishmania chagasi: importance for parasite survival in macrophages. J. Immunol. 2003, 170:2613-2620.
30. Garcia-Alonso M., Nieto A.G., Blanco A., Requena J.M., Alonso C., Navarrete I. Presence of antibodies in the aqueous humour and cerebrospinal fluid during Leishmania infections in dogs. Pathological features at the central nervous system. Parasite Immunol. 1996, 18:539-546.
31. Hanisch U.-K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
32. Hashim F.A., Ahmed A.E., el Hassan M., el Mubarak M.H., Yagi H., Ibrahim E.N., Ali M.S. Neurologic changes in visceral leishmaniasis. Am. J. Trop. Med. Hyg. 1995, 52:149-154.
33. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 1999, 11:125-137.
34. Huynh H.K., Dorovini-Zis K. Effects of interferon-γ on primary cultures of human brain microvessel endothelial cells. Am. J. Pathol. 1993, 142:1265-1278.
35. Ibebuike K., Mantanga L., Emereole O., Ndolo P., Kajee A., Gopal R., Pather S. Cerebellar toxoplasmosis in HIV/AIDS infant: case report and review of the literature. Neurol. Sci. 2012, 10.1007/s10072-012-0960-x.
36. Ikeda F.A., Laurenti M.D., Corbett C.E., Feitosa M.M., Machado G.F., Perry S.H.V. Histological and immunohistochemical study of the central nervous system of dogs naturally infected by Leishmania (Leishmania) chagasi. Braz. J. Vet. Res. Anim. Sci. 2007, 44:5-11.
37. Jennings V.M., Actor J.K., Lal A.A., Hunter R.L. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun. 1997, 65:4883-4887.
38. José-López R., la Fuente C.D., Añor S. Presumed brain infarctions in two dogs with systemic leishmaniasis. J. Small Anim. Pract. 2012, 53:554-557.
39. Kossodo S., Monso C., Juillard P., Velu T., Goldman M., Grau G.E. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 1997, 91:536-540.
40. Layé S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol. Brain Res. 1994, 27:157-162.
41. Lima V.M.F., Gonçalves M.E., Ikeda F.A., Luvizotto M.C.R., Feitosa M.M. Anti-Leishmania antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis. Braz. J. Med. Biol. Res. 2003, 36:485-489.
42. Lima V.M.F., Biazzono L., Silva A.C., Correa A.P.F.L., Luvizotto M.C.R. Serological diagnosis of visceral leishmaniasis by an enzyme immunoassay using protein A in naturally infected dogs. Braz. J. Vet. Res. Anim. Sci. 2005, 25:215-218.
43. -ΔΔCt method. Methods 2001, 25:402-408.
44. LukeŠ J., Mauricio I.L., Schönian G., Dujardin J.-C., Soteriadou K., Dedet J.-P., Kuhls K., Tintaya K.W.Q., Jirků M., Chocholová E., Haralambous C., Pratlong F., Oborník M., Horák A., Ayala F.J., Miles M.A. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9375-9380.
45. Ma X. TNF-α and IL-12: a balancing act in macrophage functioning. Microb. Infect. 2001, 3:121-129.
46. Ma X., Sun J., Papasavvas E., Riemann H., Robertson S., Marshall J., Bailer R.T., Moore A., Donnelly R.P., Trinchieri G., Montaner L.J. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J. Immunol. 2000, 164:1722-1729.
47. Machado G.F., Melo G.D., Moraes O.C., Souza M.S., Marcondes M., Perri S.H.V., Vasconcelos R.O. Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis. Vet. Immunol. Immunopathol. 2010, 136:340-345.
48. Madalosso G., Pellini A.C.G., Vasconcelos M.J., Ribeiro A.F., Weissmann L., Oliveira Filho G.S., Oliveira A.C.P.d.Vidal J.E. Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil. Rev. Inst. Med. Trop. Sao Paulo 2004, 46:199-202.
49. Manna L., Reale S., Viola E., Vitale F., Manzillo V.F., Michele P.L., Caracappa S., Gravino A.E. Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs. Vet. Parasitol. 2006, 142:271-280.
50. Marangoni N.R., Melo G.D., Moraes O.C., Souza M.S., Perri S.H.V., Machado G.F. Levels of matrix metalloproteinase-2 and metalloproteinase-9 in the cerebrospinal fluid of dogs with visceral leishmaniasis. Parasite Immunol. 2011, 33:330-334.
51. Mattner F., Magram J., Ferrante J., Launois P., Padova K.D., Behin R., Gately M.K., Louis J.A., Alber G. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 1996, 26:1553-1559.
52. Mauricio I.L., Stothard J.R., Miles M.A. The strange case of Leishmania chagasi. Parasitol. Today 2000, 16:188-189.
53. McRae B.L., Semnani R.T., Hayes M.P., van Seventer G.A. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 1998, 160:4298-4304.
54. Melo G.D., Machado G.F. Choroid plexus involvement in dogs with spontaneous visceral leishmaniasis: a histopathological investigation. Braz. J. Vet. Pathol. 2009, 2:69-74.
55. Melo G.D., Machado G.F. Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres. Cell Tissue Res. 2011, 346:293-304.
56. Melo G.D., Marcondes M., Machado G.F. Canine cerebral leishmaniasis: potential role of matrix metalloproteinase-2 in the development of neurological disease. Vet. Immunol. Immunopathol. 2012, 148:260-266.
57. Melo G.D., Marcondes M., Vasconcelos R.O., Machado G.F. Leukocyte entry into the CNS of Leishmania chagasi naturally infected dogs. Vet. Parasitol. 2009, 162:248-256.
58. Menezes-Souza D., Corrêa-Oliveira R., Guerra-Sá R., Giunchetti R.C., Teixeira-Carvalho A., Martins-Filho O.A., Oliveira G.C., Reis A.B. Cytokine and transcription factor profiles in the skin of dogs naturally infected by Leishmania (Leishmania) chagasi presenting distinct cutaneous parasite density and clinical status. Vet. Parasitol. 2011, 177:39-49.
59. Moreno P., Lucena R., Ginel P.J. Evaluation of primary haemostasis in canine leishmaniasis. Vet. Rec. 1998, 142:81-83.
60. Nieto C.G., Viñuelas J., Blanco A., Garcia-Alonso M., Verdugo S.G., Navarrete I. Detection of Leishmania infantum amastigotes in canine choroid plexus. Vet. Rec. 1996, 139:346-347.
61. Nimmerjahn F., Ravetch J.V. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 2008, 8:34-47.
62. Okun E., Mattson M.P., Arumugam T.V. Involvement of Fc receptors in disorders of the central nervous system. Neuromol. Med. 2010, 12:164-178.
63. Panaro M.A., Brandonisio O., Cianciulli A., Cavallo P., Lacasella V., Paradies P., Testini G., Caprariis D.D., Mitolo V., Otranto D. Cytokine expression in dogs with natural Leishmania infantum infection. Parasitology 2009, 136:823-831.
64. Penet M.-F., Viola A., Confort-Gouny S., Le Fur Y., Duhamel G., Kober F., Ibarrola D., Izquierdo M., Coltel N., Gharib B., Grau G.E., Cozzone P.J. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J. Neurosci. 2005, 25:7352-7358.
65. Peters I.R., Helps C.R., Calvert E.L., Hall E.J., Day M.J. Cytokine mRNA quantification in histologically normal canine duodenal mucosa by real-time RT-PCR. Vet. Immunol. Immunopathol. 2005, 103:101-111.
66. Petito C.K., Adkins B. Choroid plexus selectively accumulates T lymphocytes in normal controls and after peripheral immune activation. J. Neuroimmunol. 2005, 162:19-27.
67. Pinelli E., Rutten V.P., Bruysters M., Moore P.F., Ruitenberg E.J. Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production. Infect. Immun. 1999, 67:237-243.
68. Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 1991, 87:1360-1366.
69. Quan N., Mhlanga J.D.M., Whiteside M.B., McCoy A.N., Kristensson K., Herkenham M. Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei. J. Comp. Neurol. 1999, 414:114-130.
70. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998, 83:281-293.
71. Ranasinghe S., Rogers M.E., Hamilton J.G.C., Bates P.A., Maingon R.D.C. A real-time PCR assay to estimate Leishmania chagasi load in its natural sand fly vector Lutzomyia longipalpis. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:875-882.
72. Reis A.B., Martins-Filho O.A., Teixeira-Carvalho A., Giunchetti R.C., Carneiro C.M., Mayrink W., Tafuri W.L., Corrêa-Oliveira R. Systemic and compartmentalized immune response in canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 2009, 28:87-95.
73. Samoilova E.B., Horton J.L., Chen Y. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell. Immunol. 1998, 188:118-124.
74. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romão P., Silveira H. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet. Immunol. Immunopathol. 2002, 88:21-30.
75. São Paulo (Estado), Secretaria de Estado da Saúde de São Paulo (SES-SP), Superintendência de Controle de Endemias (SUCEN), Coordenadoria de Controle de Doenças (CCD) Manual de Vigilância e Controle da Leishmaniose Visceral Americana do Estado de São Paulo 2006, SES-SP, São Paulo, 161 pp.
76. Sawada M., Suzumura A., Hosoya H., Marunouchi T., Nagatsu T. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J. Neurochem. 1999, 72:1466-1471.
77. Schlüter D., Kaefer N., Hof H., Wiestler O.D., Deckert-Schlüter M. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am. J. Pathol. 1997, 150:1021-1035.
78. Seiwa C., Yamamoto M., Tanaka F., Fukutake M., Ueki T., Takeda S., Sakai R., Ishige A., Watanabe K., Akita M., Yagi T., Tanaka K., Asou H. Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination. J. Neurosci. Res. 2007, 85:954-966.
79. Snydman D.R., Walker M., Kublin J.G., Zunt J.R. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin. Infect. Dis. 2006, 42:115-125.
80. Solano-Gallego L., Llull J., Ramos G., Riera C., Arboix M., Alberola J., Ferrer L. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Vet. Parasitol. 2000, 90:37-45.
81. Solano-Gallego L., Miro G., Koutinas A., Cardoso L., Pennisi M., Ferrer L., Bourdeau P., Oliva G., Baneth G. LeishVet guidelines for the practical management of canine leishmaniosis. Parasites & Vectors 2011, 4:86.
82. Strauss-Ayali D., Baneth G., Shor S., Okano F., Jaffe C.L. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs. Int. J. Parasitol. 2005, 35:63-73.
83. Strazielle N., Khuth S.T., Murat A., Chalon A.L., Giraudon P., Belin M.F.O., Ghersi-Egea J.-F.O. Pro-Inflammatory cytokines modulate matrix metalloproteinase secretion and organic anion transport at the blood-cerebrospinal fluid barrier. J. Neuropathol. Exp. Neurol. 2003, 62:1254-1264.
84. Takata F., Dohgu S., Matsumoto J., Takahashi H., Machida T., Wakigawa T., Harada E., Miyaji H., Koga M., Nishioku T., Yamauchi A., Kataoka Y. Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro. J. Neuroinflam. 2011, 8:106.
85. Turner G. Cerebral malaria. Brain Pathol. 1997, 7:569-582.
86. Untergasser A., Nijveen H., Rao X., Bisseling T., Geurts R., Leunissen J.A.M. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 2007, 35:W71-W74.
87. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743.
88. Viñuelas J., Garcia-Alonso M., Ferrando L., Navarrete I., Molano I., Mirón C., Carcelén J., Alonso C., Nieto C.G. Meningeal leishmaniosis induced by Leishmania infantum in naturally infected dogs. Vet. Parasitol. 2001, 101:23-27.
89. Watford W.T., Moriguchi M., Morinobu A., O'Shea J.J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003, 14:361-368.
90. Yong V.W., Moumdjian R., Yong F.P., Ruijs T.C., Freedman M.S., Cashman N., Antel J.P. γ-Interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:7016-7020.